What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Gene
Michael R. Verneris mostly deals with Immunology, Interleukin 21, Transplantation, Interleukin 12 and Lymphokine-activated killer cell.
His studies deal with areas such as Stem cell and Degranulation as well as Immunology.
The concepts of his Interleukin 21 study are interwoven with issues in Cytokine and Cell biology.
His Transplantation study is concerned with Internal medicine in general.
His Internal medicine research incorporates elements of Gastroenterology, Transplantation Conditioning and Surgery.
His Interleukin 12 research is multidisciplinary, incorporating elements of Natural killer T cell and Natural killer cell.
His most cited work include:
- Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia (1540 citations)
- Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C natural killer cells with potent function (434 citations)
- Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood (402 citations)
What are the main themes of his work throughout his whole career to date?
Michael R. Verneris spends much of his time researching Transplantation, Immunology, Internal medicine, Hematopoietic stem cell transplantation and Oncology.
His Transplantation study incorporates themes from Hematopoietic cell, Umbilical cord, Leukemia and Human leukocyte antigen.
His studies deal with areas such as Natural killer cell and Stem cell as well as Immunology.
His Internal medicine study combines topics from a wide range of disciplines, such as Gastroenterology and Surgery.
His research investigates the link between Hematopoietic stem cell transplantation and topics such as T cell that cross with problems in CD8.
The various areas that Michael R. Verneris examines in his Interleukin 21 study include Natural killer T cell, Interleukin 12 and Cell biology.
He most often published in these fields:
- Transplantation (48.55%)
- Immunology (44.33%)
- Internal medicine (42.48%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (42.48%)
- Transplantation (48.55%)
- Oncology (20.32%)
In recent papers he was focusing on the following fields of study:
Michael R. Verneris focuses on Internal medicine, Transplantation, Oncology, Hematopoietic stem cell transplantation and Immunology.
Many of his studies involve connections with topics such as Gastroenterology and Internal medicine.
His Transplantation research is multidisciplinary, relying on both Young adult, Hematopoietic cell, Umbilical cord and Cohort.
Michael R. Verneris works mostly in the field of Oncology, limiting it down to topics relating to B-cell acute lymphoblastic leukemia and, in certain cases, Relapsed refractory, as a part of the same area of interest.
Michael R. Verneris combines subjects such as T cell, Human leukocyte antigen, Histocompatibility and Acute leukemia with his study of Hematopoietic stem cell transplantation.
His research brings together the fields of Natural killer cell and Immunology.
Between 2017 and 2021, his most popular works were:
- Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia (1540 citations)
- Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia (155 citations)
- First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation (141 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Gene
Michael R. Verneris focuses on Transplantation, Internal medicine, Hematopoietic stem cell transplantation, Oncology and Young adult.
He interconnects Hematopoietic cell, Umbilical cord, CD8 and Cohort in the investigation of issues within Transplantation.
The concepts of his Internal medicine study are interwoven with issues in Gastroenterology and Histocompatibility.
His study focuses on the intersection of Gastroenterology and fields such as Cord blood with connections in the field of Regimen.
His Hematopoietic stem cell transplantation research includes elements of Myeloid, Hazard ratio, Confidence interval, Graft-versus-host disease and Leukemia.
Michael R. Verneris has researched Survival analysis in several fields, including Chimeric Antigen Receptor T-Cell Therapy and Monoclonal.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
